cholangiocarcinoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

cholangiocarcinoma
Dec 18, 2024, 12:42 | Insight
Renuka Iyer: A big milestone in Cholangiocarcinoma care
Renuka Iyer, Professor at Roswell Park Cancer Institute, shared a post on LinkedIn about a…
Nov 24, 2024, 07:52 | Drugs
U.S. FDA Approval of Ziihera for the Previously Treated, Unresectable or IHC 3+ Biliary Tract Cancer
Ziihera is a targeted treatment used to treat HER2-positive biliary tract cancer (BTC) that has already been…
Nov 15, 2024, 12:21 | Insight
Ahmed Abbass: Managing Cholangiocarcinoma with Precision Oncology Approach
Ahmed Abbass, Fellow in Medical Oncology at University College London Hospitals NHS Foundation Trust, shared…
Nov 5, 2024, 17:49 | Blog
Flavio Rocha: Delighted to open the surgical program at 7th Annual AP Cholangiocarcinoma Foundation Conference
Flavio Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute, shared a…
Oct 2, 2024, 12:10 | Dialogues
ASCO24 Updates: Dr. Riya Jayesh Patel on Genomic Signatures and Survival in Cholangiocarcinoma
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Sep 17, 2024, 16:13 | Blog
Angela Lamarca as a discussant at the Presidential Session of ESMO24 - Cholangiocarcinoma Foundation
Cholangiocarcinoma Foundation shared on X: "We’re proud to see Angela Lamarca as a discussant at the…
Aug 24, 2024, 07:04 | Blog
2024 Chicago Cholangiocarcinoma Symposium
The 2024 Chicago Cholangiocarcinoma Symposium will be held in Chicago, bringing together top experts, researchers,…
Jul 20, 2024, 18:17 | Blog
Stacie Lindsey: Looking forward to the 2024 Chicago Cholangiocarcinoma Symposium
Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared a post on X/Twitter by Cholangiocarcinoma Foundation adding:…
Jul 15, 2024, 11:28 | Insight
Meng-Ju Wu: IDH1 inhibition activates tumor immunity by inducing dsDNA sensing
Meng-Ju Wu, Instructor at Harvard Medical School and Massachusetts General Hospital, shared on X about…
Jul 14, 2024, 06:22 | Insight
Anirban Maitra: Another spectacular study from Nabeel Bardeesy on Mutant IDH1 inhibition
Anirban Maitra shared a post on X about a recent paper by Nabeel Bardeesy et…
Jul 12, 2024, 13:32 | Blog
2024 Research Fellows' Institutions
Stacie Lindsey, CEO and Founder of the Cholangiocarcinoma Foundation, shared a post on X: "Since 2015,…
Jul 10, 2024, 12:20 | Blog
Anirban Maitra: Impressive resource and dataset for bile duct cancers
Anirban Maitra shared an article by Michel Botros et al. on X, adding the following:…
Jul 9, 2024, 04:35 | Blog
Arndt Vogel: Nanoliposomal irinotecan and 5-FU in cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies
Arndt Vogel shared on X: “Now fully published Nanoliposomal irinotecan & 5-FU in cholangiocarcinoma &…
Jul 4, 2024, 12:15 | Blog
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…
Jun 21, 2024, 08:07 | Insight
A case of cholangiocarcinoma type IV block from Kazakistan
Vrishit Saraswat, Interventional Radiologist at Medanta Hospital, shared on LinkedIn: "October ’23: Young male, early…
Jun 20, 2024, 01:53 | Insight
Miguel Bronchud: ESMO recommends performing tumour NGS to detect tumour-agnostic alterations in patients with metastatic cancers
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “2024- ESMO of course recommends…
Jun 15, 2024, 05:47 | Blog
Nicholas Hornstein: Cholangiocarcinoma patients post gemcitabine based treatment by Arndt Vogel et al
Nicholas Hornstein, Oncology Fellow at MD Anderson Cancer Center, shared a post on X: "Phase 2…
Jun 14, 2024, 16:10 | Insight
Ghassan Abou-Alfa on a paper by Arndt Vogel et al.
Ghassan Abou-Alfa, a Medical Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on…
Jun 9, 2024, 06:07 | Blog
Thomas J. Ettrich: Final results of our NIFE trial now published in 'Journal of Clinical Oncology'
Thomas J. Ettrich, Senior Physician, Department of Internal Medicine, University of Ulm, shared a post on…
May 25, 2024, 13:32 | Blog
Husch Blackwell Strategies - Gregg Hartley joined Marina Baretti to encourage Congress to invest into research for cholangiocarcinoma
Husch Blackwell Strategies shared a post on LinkedIn: "HBS Executive Vice Chairman and COO Gregg Hartley…
May 23, 2024, 15:07 | Blog
Stacie Lindsey: Melinda Bachini's story exemplifies how self-advocacy and participation in a clinical trial can contribute to the progress in treating cholangiocarcinoma
Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared a post by Cholangiocarcinoma Foundation on LinkedIn, adding: “Advocacy…
May 5, 2024, 13:13 | Blog
Dr. Tim Greten receives 2024 Innovation Grant from the Cholangiocarcinoma Foundation! - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "STAFF SPOTLIGHT: Congratulations to Dr. Tim Greten, the…
May 3, 2024, 14:50 | Insight
New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma
Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma Authors: Matthew D. Robinson, Roseanna Wheatley, Lucy Foster,…
Apr 21, 2024, 23:34 | Blog
Svetlana Nikic: Comprehensive and structured list of FDA-approved CDx NGS assays. Super easy to be found at FDA's website
Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn: "With an overwhelming amount…
Apr 15, 2024, 17:06 | Drugs
Biliary tract cancers therapeutic studies summarized by Erman Akkus at AACR
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: “Biliary tract cancers- therapeutic studies…
Apr 7, 2024, 15:55 | Opinion
Udhayvir Grewal: Carver College of Medicine MS3 Srija Manchkanti will be presenting our work on cholangiocarcinoma in primary sclerosing cholangitis at ASCO24
Udhayvir Grewal, Hematology/Onoclogy Fellow at The University of Iowa Holden Comprehensive Cancer Center, made the…
Feb 26, 2024, 11:06 | Stories
Daniella T.: Even if we’re apart… I’ll always be with you
Daniella T. shared on LinkedIn: "If you’re reading this then it means I have died…
Feb 4, 2024, 18:08 | Blog
February is Gallbladder and Bile Duct Cancer Awareness Month
February is Gallbladder and Bile Duct Cancer Awareness Month! Although rare, gallbladder and bile duct…
Oct 31, 2023, 15:46 | Blog
Toufic Kachaamy: Success is not just about groundbreaking discoveries, but in the collaboration and unity of minds
Toufic Kachaamy, Enterprise Clinical Leader and Interventional Program Specialist at City of Hope, stated the…
Sep 23, 2023, 19:57 | Blog
The first-ever ESMO Advanced Course on cholangiocarcinoma just took place in Barcelona. - The European Society for Medical Oncology (ESMO)
Quoting The European Society for Medical Oncology (ESMO) on X/Twitter: "The first-ever ESMO Advanced Course…
Aug 9, 2023, 18:22 | Insight
An incredible collaborative effort between patients and research team which began in 2014 trying to understand lesser known risk factors to developing intra (ICC) and extrahepatic (ECC) cholangiocarcinoma - Madhu Eluri
Jul 5, 2023, 04:13 | Drugs
European Commission Grants Conditional Marketing Authorization for Futibatinib for the Treatment of Adults With Cholangiocarcinoma
In a post by Arndt Vogel on Twitter, it says, "European Commission Grants Conditional Marketing…
Jul 2, 2023, 08:55 | Stories
I wanted to share my experience as a patient from oncology pharmacist’s perspective - Sara Kim
My memoir on my recent medical journey is published on amazon! It is self-published and…
All: 33 Posts: 1 - 100
Special Coverage